Uncategorized
Zucara Therapeutics, an adMare & TIAP Spin-off Company, Announces $21M Series A Financing
March 31, 2020
The proceeds from the financing will fund Phase 1 & Phase 2 clinical trials of ZT-01, Zucara’s first-in-class drug candidate designed...
Read the article